Literature DB >> 22354317

Immune regulation of procalcitonin: a biomarker and mediator of infection.

G N Matwiyoff1, J D Prahl, R J Miller, J J Carmichael, D E Amundson, G Seda, M Daheshia.   

Abstract

Procalcitonin (PCT) has recently emerged as a powerful biomarker for an early and accurate diagnosis of bacterial infection. Here we summarize our current understanding of the expression pathways of PCT, its potential cellular sources including immune cells, and factors inducing its secretion. Also addressed is the significance of increased blood PCT concentration, which may allow this molecule not only to act as a clinical biomarker but also as an active participant in the development and progression of infectious processes. Experimental approaches to delineate a better understanding of PCT functions, molecular pathways that modulate its expression and therapeutic opportunities to curtail its biological actions are discussed, as well.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354317     DOI: 10.1007/s00011-012-0439-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  78 in total

Review 1.  Molecular aspects and natural source of procalcitonin.

Authors:  S Russwurm; M Wiederhold; M Oberhoffer; I Stonans; P F Zipfel; K Reinhart
Journal:  Clin Chem Lab Med       Date:  1999-08       Impact factor: 3.694

2.  Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs.

Authors:  Kristin E Wagner; Jose M Martinez; Steven D Vath; Richard H Snider; Eric S Nylén; Kenneth L Becker; Beat Müller; Jon C White
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

3.  [Influrence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood aganist bacteria Staphylococcus aureus and Escherichia coli].

Authors:  T Pincíková; M Bucová; L Slobodníková
Journal:  Vnitr Lek       Date:  2005-12

4.  Procalcitonin estimation in Kawasaki disease.

Authors:  Subroto Chakrabartty; S Apong
Journal:  Indian Pediatr       Date:  2009-07       Impact factor: 1.411

5.  Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes.

Authors:  Attila Balog; Imre Ocsovszki; Yvette Mándi
Journal:  Immunol Lett       Date:  2002-12-03       Impact factor: 3.685

6.  Heterogeneity of immunoreactive calcitonin in normal human thyroid.

Authors:  A Jullienne; D Raulais; C Calmettes; M S Moukhtar; G Milhaud
Journal:  Horm Metab Res       Date:  1978-09       Impact factor: 2.936

7.  Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock.

Authors:  José R Fioretto; Joelma G Martin; Cilmery S Kurokawa; Mário F Carpi; Rossano C Bonatto; Marcos A de Moraes; Sandra M Q Ricchetti
Journal:  Inflamm Res       Date:  2010-02-04       Impact factor: 4.575

8.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

Authors:  E S Nylen; K T Whang; R H Snider; P M Steinwald; J C White; K L Becker
Journal:  Crit Care Med       Date:  1998-06       Impact factor: 7.598

Review 9.  Cyclic AMP: master regulator of innate immune cell function.

Authors:  Carlos H Serezani; Megan N Ballinger; David M Aronoff; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-06       Impact factor: 6.914

10.  Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.

Authors:  Pierre Emmanuel Charles; Sylvain Ladoire; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Sébastien Prin; Niels-Olivier Olsson; Bernard Blettery
Journal:  BMC Infect Dis       Date:  2008-03-26       Impact factor: 3.090

View more
  26 in total

Review 1.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

2.  Serum Procalcitonin Levels are Associated with Clinical Outcome in Intracerebral Hemorrhage.

Authors:  Dingxiu He; Yun Zhang; Biao Zhang; Wei Jian; Xiaojian Deng; Yi Yang; Tao Xiao; Hanyang Yu; Shuyin Wen; Kaisen Huang
Journal:  Cell Mol Neurobiol       Date:  2017-08-20       Impact factor: 5.046

3.  Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment.

Authors:  Wen Li; Xiaolong Sun; Fang Yuan; Qiong Gao; Yue Ma; Yongli Jiang; Xiai Yang; Fang Yang; Lei Ma; Wen Jiang
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

4.  Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Authors:  Mira Katan; Yeseon P Moon; Myunghee C Paik; Beat Mueller; Andreas Huber; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-05-19       Impact factor: 7.914

5.  Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.

Authors:  Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang
Journal:  Respirology       Date:  2014-01-26       Impact factor: 6.424

6.  Intravenous immunoglobulin preparation prevents the production of pro-inflammatory cytokines by modulating NFκB and MAPKs pathways in the human monocytic THP-1 cells stimulated with procalcitonin.

Authors:  Kazuki Murakami; Chiaki Suzuki; Akihiro Fujii; Fujio Kobayashi; Atsushi Nakano; Akihito Kamizono
Journal:  Inflamm Res       Date:  2014-05-29       Impact factor: 4.575

7.  DNA methylation pattern of CALCA in preterm neonates with bacterial sepsis as a putative epigenetic biomarker.

Authors:  Kristina A Tendl; Stefan M F Schulz; Thomas P Mechtler; Adele Bohn; Thomas Metz; Susanne Greber-Platzer; David C Kasper; Kurt R Herkner; Chike B Item
Journal:  Epigenetics       Date:  2013-10-17       Impact factor: 4.528

8.  Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.

Authors:  Yinzhi Leng; Caiyun Chen; Yongxiang Zhang; Can Luo; Bo Liu
Journal:  Ann Transl Med       Date:  2019-04

9.  Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.

Authors:  Guomei Shi; Minghao Li; Rujuan Zhou; Xiaorong Wang; Wu Xu; Feng Yang; Shouru Xue
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

Review 10.  Future Biomarkers for Infection and Inflammation in Febrile Children.

Authors:  Judith Zandstra; Ilse Jongerius; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.